EarningsQ2 2023 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q2 2023 Earnings Report

0 Followers

MX:ARWR Q2 2023 EPS Results

Actual EPS$8.21

Consensus EPS-$11.28

Beat/MissBeat by +$19.50

One Year Ago EPS$7.48

Actual Revenue$2.67B

Expected Revenue$830.20M

Beat/MissBeat by +$1.84B

YoY Revenue Growth-3.65%

QuarterQ2 2023

Date05/02/2023

TimeAfter Close

Conference CallTuesday, May 2, 2023

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

MX:ARWR Q2 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-28.31 / -	-2.008	―
Aug 04, 2026	2026 (Q3)	-23.31 / -24.83	-23.001	-7.94% (-1.83)
May 07, 2026	2026 (Q2)	-19.99 / -16.98	50.2	-133.82% (-67.18)
Feb 05, 2026	2026 (Q1)	0.68 / 4.02	-25.374	115.83% (+29.39)
Nov 25, 2025	2025 (Q4)	-2.04 / -2.01	-24.826	91.91% (+22.82)
Aug 07, 2025	2025 (Q3)	-17.38 / -23.00	-25.191	8.70% (+2.19)
May 12, 2025	2025 (Q2)	-3.41 / 50.20	-18.62	369.61% (+68.82)
Feb 10, 2025	2025 (Q1)	-8.69 / -25.37	-22.636	-12.10% (-2.74)
Nov 26, 2024	2024 (Q4)	-20.45 / -24.83	-18.62	-33.33% (-6.21)
Aug 08, 2024	2024 (Q3)	-9.66 / -25.19	-17.524	-43.75% (-7.67)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed